Accessibility of the World Health Organization's eTB Catalogue of Recommendations
Comparing the Accessibility of the World Health Organization's Tuberculosis Guidelines to the eTB Catalogue of Recommendations: A Two-Arm Superiority Randomized Controlled Trial
1 other identifier
interventional
244
1 country
1
Brief Summary
The World Health Organization's Global Tuberculosis Programme (WHO-GTB) issues evidence-informed guideline recommendations on tuberculosis (TB). These recommendations are used by decision-makers, guideline developers and other stakeholders. In an effort to improve the accessibility and usability of these recommendations, a new eTB catalogue of recommendations has been developed. This study aims to compare the accessibility of the new eTB catalogue to the earlier method of accessing recommendations directed through the general WHO website.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2021
CompletedFirst Posted
Study publicly available on registry
February 9, 2021
CompletedStudy Start
First participant enrolled
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2021
CompletedDecember 13, 2021
December 1, 2021
6 months
February 4, 2021
December 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accessibility of Information on a Seven-Point Likert Scale
The primary outcome is the accessibility of information on the eTB catalogue compared to the current WHO TB guidelines. Accessibility is defined as the ability to access and use information. This outcome considers the four following domains: (1) how easy is it to find the information (2) how easy is it to understand the information (3) whether the presentation of this information facilitates decision-making (4) overall accessibility of information. These domains will be measured using a seven-point Likert scale (1 = strongly disagree, 7 = strongly agree). The statements will be: 'It was easy to find the information', 'it was easy to understand the information', 'the information was presented in a way that would help me make a decision', and 'this website was easy to navigate'. The investigators will calculate mean composite values of these four domains for the primary outcome of accessibility, and present the four individual domains as secondary outcomes.
Duration of survey (approximately 10 minutes)
Secondary Outcomes (3)
Satisfaction on a Seven-Point Likert Scale
Duration of survey (approximately 10 minutes)
Understanding with Multiple Choice Questions
Duration of survey (approximately 10 minutes)
Preference on a Seven-Point Likert-Scale
Duration of survey (approximately 10 minutes)
Study Arms (2)
eTB Catalogue of Recommendation (eTB)
EXPERIMENTALNew eTB catalogue of recommendations website (eTB).
World Health Organization Tuberculosis Website (WHO TB)
ACTIVE COMPARATORCurrent method of accessing tuberculosis (TB) recommendations using World Health Organization (WHO) website (WHO TB).
Interventions
eTB Catalogue of Recommendations (eTB)
World Health Organization Tuberculosis Website (WHO TB)
Eligibility Criteria
You may qualify if:
- Stakeholders who consider themselves to be users or potential users of tuberculosis (TB) recommendations will be eligible for participation. For the purposes of this trial, a user is defined as someone who has previously accessed TB guidelines, recommendations or policy advice, and a potential user is someone who plans to access TB guidelines, recommendations, or policy advice in the future.
- Participants may be part of any group that has a stake in TB, including the public, healthcare providers, policymakers, or researchers. Participants may be from either low- and middle-income countries (LMIC) or high-income countries (HIC).
- They may also vary in levels of education and previous TB work experience.
You may not qualify if:
- Individuals involved in eTB catalogue development.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster University
Hamilton, Ontario, L8S 4L8, Canada
Related Publications (1)
Matthews M, Lotfi T, Santesso N, Loeb M, Mertz D, Chagla Z, Hajizadeh A, Piggott T, Dietl B, Schunemann HJ. Comparing the usability of the World Health Organization's conventional tuberculosis guidelines to the eTB recommendations map: A two-arm superiority randomised controlled trial. PLOS Glob Public Health. 2022 Oct 14;2(10):e0001166. doi: 10.1371/journal.pgph.0001166. eCollection 2022.
PMID: 36962671DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Holger J Schunemann, MD, PhD
McMaster University
- PRINCIPAL INVESTIGATOR
Micayla N Matthews, BHSc
McMaster University
- STUDY DIRECTOR
Tamara Lotfi, MD, MPH
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
February 9, 2021
Study Start
February 26, 2021
Primary Completion
August 29, 2021
Study Completion
August 29, 2021
Last Updated
December 13, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share